• Innovation During COVID-19 Townhall: Progress Towards COVID-19 Therapeutics

    • Share:
    Name: Innovation During COVID-19 Townhall: Progress Towards COVID-19 Therapeutics
    Date: July 22, 2020
    Time: 1:00 PM - 2:30 PM EDT
    Website: Register here!
    Event Description:
    America’s biopharmaceutical companies’ have acted quickly to focus their expertise on treatments for COVID-19. Currently, treatments being tested range from antiviral and antibody therapies to anticoagulant and antimicrobial therapies – to target both the virus itself and the most dangerous health consequences of COVID-19.
    Please join PhRMA member company executives for a townhall on COVID-19 therapeutic development – a unique forum to hear directly from leaders in the fight to beat COVID-19, including:
    • Ramona Sequeira, President, Takeda
    • David Ricks, Chairman and Chief Executive Officer, Eli Lilly and Company
    • Alexander Hardy, Chief Executive Officer, Genentech
    • Johanna Mercier, Chief Commercial Officer, Gilead
     If you wish to submit a question for the panel, please use the registration link or email phrma_alliance@phrma.org by close of business Friday, July 17th.
    Date/Time Information:
    July 22
    1:00 - 2:30 p.m.
    Contact Information:
    Hosted by PhRMA
    Please click here to RSVP to the event.
    Dial-in information will be shared with those who RSVP on
    Tuesday, July 21st.
    Set a Reminder:
    Enter your email address below to receive a reminder message.
    Your reminder has been successfully scheduled. An email will be sent to the specified email address 1 day before the event.
  • NCBIO Events

  • Latest Tweets